Papers
3
Total Citations
107
H-Index
2
About
Kamil Malshy is a urologic researcher whose work centers on improving surgical outcomes and diagnostic precision in prostate and bladder cancer. His most influential contribution examines the association between PSA density and pathologically significant prostate cancer, demonstrating how prostate volume impacts risk stratification. This 2020 study, with 103 citations, has helped refine biopsy decision-making, reducing the detection of clinically insignificant disease. Malshy has also advanced surgical technique, evaluating the safety and efficacy of biological glue (Starsil® Hemostat) in robotic partial nephrectomy to minimize perioperative bleeding—a critical complication in nephron-sparing surgery. More recently, his 2025 investigation into neoadjuvant chemotherapy’s impact on short-term complications following robotic radical cystectomy provides valuable data for optimizing bladder cancer treatment pathways. Through these studies, Malshy bridges diagnostic innovation and surgical refinement, offering evidence that directly informs clinical practice. His work is particularly relevant for researchers and clinicians seeking to enhance cancer care through personalized risk assessment and safer robotic procedures.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3